Jaroslav Bendl, PhD
About Me
Jaroslav Bendl, PhD, is an Assistant Professor at the Department of Psychiatry and the Department of Genetics and Genomic Sciences. A major focus of Dr. Bendl’s research has been developing computational methods and databases to annotate and interpret human genomics, epigenomics, and transcriptomic data to better understand neuropsychiatric and neurodegenerative disorders. Notably, as a member of AMP-AD and PsychENCODE consortia, he has led the computational analysis of epigenetic changes in the two largest cohorts of postmortem brains associated with Alzheimer’s disease and Schizophrenia. Prior to joining ISMMS, he was a lead developer of several software tools for the prediction of the effect of genome mutations on protein function (PredictSNP 1/2) and enzyme design (HotSpot Wizard), the latter one was successfully commercialized by Enantis, a biotechnology spinoff from Masaryk University. Dr. Bendl is a former recipient of the Young Investigator Award from the Brain & Behavior Research Foundation (2019-2021) and a current holder of Alzheimer’s Association Research Fellowship (2021-2023).
Language
English
Position
ASSISTANT PROFESSOR | Psychiatry, ASSISTANT PROFESSOR | Genetics and Genomic Sciences
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Dr. Bendl has not yet completed reporting of Industry relationships.
Mount Sinai’s faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.